Login / Signup

FDA's Benefit-Risk Framework for Human Drugs and Biologics: Role in Benefit-Risk Assessment and Analysis of Use for Drug Approvals.

Leila LackeyGraham ThompsonSara Eggers
Published in: Therapeutic innovation & regulatory science (2020)
FDA's BRF provides a flexible mechanism for communicating important decision factors, allowing it to support the diversity of drug approval decisions made by FDA.
Keyphrases
  • risk assessment
  • endothelial cells
  • drug induced
  • adverse drug
  • human health
  • induced pluripotent stem cells
  • heavy metals
  • pluripotent stem cells
  • emergency department
  • drug administration